Company Active LTD

Company profile

Mesenbio Limited

Mesenbio Limited is a UK company with status active founded in 2021 based in Yorkshire and the Humber.

CRN
13783719
Founded
2021
Age
4

Overview

Legal name
MESENBIO LIMITED
Region
Yorkshire and the Humber
Registered address
UNIVERSITY OF YORK WENTWORTH WAY
BIOLOGY DEPARTMENT
YORK
ENGLAND
YO10 5DD
Insolvency history
No

Latest accounts

Financial period: 1 Jan 2024 to 31 Dec 2024

FILLETEDACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
5

Company events

Reference milestones and recent Companies House filing stream events.

7 events
30 Sep
2027

Accounts due

Accounts Due

Next accounts due date

19 Dec
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Dec
2025

Accounts filed

Accounts

Last accounts made up date

05 Dec
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

25 Feb
2025

Confirmation Statement With Updates

Confirmation-statement

CS01 | Transaction MzQ1NjMyNTc1M2FkaXF6a2N4 | Paper/PDF filed

Published 25 Feb 2025 12:19

25 Sep
2024

Accounts With Accounts Type Micro Entity

Accounts Analysed

AA | Transaction MzQzNzE1MTQwNGFkaXF6a2N4

Published 25 Sep 2024 08:13

06 Dec
2021

Incorporated

Inception

Company registered at Companies House

Public funding

1 award
First funded
2024
Funded years
2024
Age at first award
2 years

Projects

2024 Collaborative R&D Lead participant

Preclinical development of an extracellular vesicle biotherapeutic for juvenile idiopathic arthritis

1 Jan 2024 to 30 Jun 2026

Awarded
£854,834
Total cost £1,221,192

Mesenbio's aim is to accelerate the clinical development of extracellular vesicle (EV) biotherapeutics. We have engineered a human mesenchymal stem cell line to produce a limitless, consistent supply EVs with intrinsic anti-inflammatory and tissue regenerating properties. Our intention is to develop these EVs as a disruptive new therapy for inflammatory a...

Product types

Collaborative R&D